OCTREOTIDE 1,000 MCG/5 ML VIAL
For 5 mL
Pharmacies pay
$26.70 filed
5 × $5.3404 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$44.07 filed
5 × $8.81304 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.7× estimated
Medicare paid 1.7× what pharmacies pay.
Part D averages every strength and form sold under “Octreotide Acetate” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-04-22 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$35.71 estimated
$26.70 + $4.01 (15%) + $5.00 fee per fill = $35.71
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-04-22 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
OCTREOTIDE 1,000 MCG/5 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as octreotide acetate, under the trade name “Octreotide”.
FDA gives its dosage form as injection, solution and its route as “intravenous; subcutaneous” and “intravenous; intravenous”.
Its labelers, the companies named on the label, are Hikma Pharmaceuticals USA Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Fresenius Kabi USA, LLC.
FDA’s Established Pharmacologic Class for it is Somatostatin Analog.
The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes); the FDA directory lists 3 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $26.70 for 5 mL (5 × $5.3404 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-04-22. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size.
The NADAC of all 4 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-04-22. The file is new; the price is not.
What NADAC measures · NADAC explanation codes · Carried-forward prices
All 4 NDCs
- 00641-6177-01 · Hikma Pharmaceuticals USA Inc. · $5.3404 per ML · eff. 2026-04-22 filed carried forward
- 23155-0685-31 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $5.3404 per ML · eff. 2026-04-22 filed carried forward
- 25021-0466-05 · not listed as a package in the FDA directory · $5.3404 per ML · eff. 2026-04-22 filed carried forward
- 63323-0378-05 · Fresenius Kabi USA, LLC · $5.3404 per ML · eff. 2026-04-22 filed carried forward
Other strengths, forms and brands
6 other products in the NADAC file share the FDA nonproprietary name octreotide acetate with OCTREOTIDE 1,000 MCG/5 ML VIAL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| OCTREOTIDE 1,000 MCG/5 ML VIAL this page | $5.3404 per ML filed | $8.81304 per ML filed |
| OCTREOTIDE ACET 50 MCG/ML VIAL | $2.6422 per ML filed | $8.81304 per ML filed |
| OCTREOTIDE ACET 100 MCG/ML SYR | $5.24 per ML filed | $8.81304 per ML filed |
| OCTREOTIDE ACET 100 MCG/ML VL | $2.53458 per ML filed | $8.81304 per ML filed |
| SANDOSTATIN LAR DEPOT 10 MG KT | $3,523.02912 per EA filed | $5,143.24868 per EA filed |
| SANDOSTATIN LAR DEPOT 20 MG KT | $4,588.54686 per EA filed | $5,143.24868 per EA filed |
| SANDOSTATIN LAR DEPOT 30 MG KT | $6,948.084 per EA filed | $5,143.24868 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22, 2026-07-08, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 4 NDCs’ NADAC prices is $5.3404 per ML filed.
Of the 3 other products in FDA’s Somatostatin Analog class priced per ML, 0 have a higher middle NADAC price and 3 a lower one. The one in the middle is OCTREOTIDE ACET 50 MCG/ML VIAL, at $2.6422 per ML filed (eff. 2026-04-22).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-04-22 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $44.07 for 5 mL, at an average of $8.81304 per ML in 2024 (2024-01-01 to 2024-12-31) for “Octreotide Acetate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 14,690 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
3 of the product’s 4 NDCs have this Medicare figure; the other 1 do not, and the interactive card says why for each.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 5 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 5 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for OCTREOTIDE 1,000 MCG/5 ML VIAL labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Octreotide Acetate / Octreotide Acetate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
- Why does this page start at 5 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 5 mL in one package for the 3 of this product’s 4 NDCs it lists (“1 VIAL, MULTI-DOSE in 1 CARTON (0641-6177-01) / 5 mL in 1 VIAL, MULTI-DOSE”), so the card starts at one package: 5 ML. Change it to match your prescription.